Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery

NCT04452461 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: mFOLFIRINOX
DRUG: Gemcitabine / Nab-paclitaxel

Sponsor

Hamilton Health Sciences Corporation